BOLTON SECURITIES CORPORATION’s Nephros NEPH Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.5K	Buy	+7,231	New	+$28.9K	﹤0.01%	1435

Other funds holding NEPH

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cornerstone Capital Palo Alto, California $1.09B AUM 22.93% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Mesirow Financial Investment Management Chicago, Illinois $6.47B AUM 15.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's NEPH Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Nephros (NEPH) in Q1 2026: 7,231 shares worth $21.5K. The stake represents ﹤0.01% of the portfolio and ranks #1435 among its holdings.

28 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

BOLTON SECURITIES CORPORATION held 7,231 shares of Nephros worth $21.5K as of Q1 2026.
Nephros was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
Nephros made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1435 holding.
28 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.